diabetes info treatment caregiver research new diagnosis | type 2 |
Posted in New diabetes treatments @ February 17, 2009
Current first-line therapies for diabetic nephropathy work on the angiotensin-renin system, but avosentan is a once-daily, oral agent that targets the endothelin system's regulation of renal function. ...
Tags: system, oral, daily, avosentan, agent